ReviewJournal of cancer research and clinical oncology2023
NOTCH3 missense mutations as predictor of long-term response to gemcitabine in a patient with epithelioid hemangioendothelioma.
Moritz Schmidt et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.